Basic Information
Basic information for SNHG14-291-16aa
Peptide Name SNHG14-291-16aa
Genome Position chr15:25059547-25059594[+]
Species Human
Peptide Sequence MSPPKKTFLGKAEQNE
Peptide Length 16
Unique No (SNHG14-211-16aa,SNHG14-224-16aa,SNHG14-231-16aa-2,SNHG14-234-16aa,SNHG14-248-16aa,SNHG14-254-16aa,SNHG14-261-16aa,SNHG14-269-16aa,SNHG14-272-16aa,SNHG14-282-16aa,SNHG14-304-16aa,SNHG14-309-16aa,SNHG14-313-16aa,SNHG14-318-16aa,SNHG14-323-16aa,SNHG14-332-16aa)
Grand Average of Hydropathicity -1.2812
Relative Molecular Mass 2075.34
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000664545;SNHG14-291
Transcript Length 5278
Coding Ability 0.5176
DNA Sequence Corresponding to Peptide ATGAGTCCCCCCAAAAAAACATTCCTTGGAAAAGCTGAACAAAATGAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :